Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1993-06-02
1995-03-14
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, C07C40100
Patent
active
053977750
ABSTRACT:
Vitamin D.sub.2 analogs in which a cyclopentane ring is introduced onto the 25-carbon of the side chain of 1.alpha.,25-dihydroxyvitamin D.sub.2 and its 24-epimer. The compounds are characterized by a marked intestinal calcium transport activity while exhibiting much lower activity than 1.alpha.,25-dihydroxyvitamin D.sub.3 in their ability to mobilize calcium from bone. Because of their preferential calcemic activity, these compounds would be useful for the treatment of diseases where bone formation is desired, such as osteoporosis.
REFERENCES:
patent: 4588716 (1986-05-01), DeLuca et al.
patent: 4769181 (1988-09-01), DeLuca et al.
patent: 4851401 (1989-07-01), DeLuca et al.
patent: 4973584 (1990-11-01), DeLuca et al.
De Luca Hector F.
Nakagawa Naoshi
Kestler Kimberly J.
Richter Johann
Wisconsin Alumni Research Foundation
LandOfFree
26,27-dimethylene-1.alpha.,25-dihydroxyvitamin D.sub.2 and 26,27 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 26,27-dimethylene-1.alpha.,25-dihydroxyvitamin D.sub.2 and 26,27, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 26,27-dimethylene-1.alpha.,25-dihydroxyvitamin D.sub.2 and 26,27 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-713843